Geoff Klass

Geoff Klass is the current CEO at Sense Neuro Diagnostics. Prior to that, they were the Executive Vice President at Circuit Clinical from September 2016 to January 2018. Their responsibilities there included Business Development, Strategic Planning, Operational Excellence, and Senior Advisor.

From January 2008 to December 2011, Geoff was the Senior Vice President, Global Business Excellence Group at Pfizer. In this role, they were responsible for establishing the Global Business Excellence Group, a change management group charged with developing and improving core business processes and regional business processes across Pfizer’s global operations.

From January 2004 to December 2007, Geoff served as the Chief Operating Officer of the Jacobs Neurological Institute. In this role, they were responsible for the financial management and business development activities of the not-for-profit institute, including expansion of the research and clinical activities of the Baird MS Center, Buffalo Neurological Imaging Analysis Center, Pediatric Neurology, Epilepsy Center as well as the activities of the University Neurology practice plan. During their tenure, Geoff led a financial and operational turnaround of the Jacobs Neurological Institute, returning it to profitability within nine months. Geoff also created, in conjunction with Dr. L. Nelson Hopkins, the concept for the Jacobs Institute, a world-class clinical, research, academic and entrepreneurial entity that would collaborate with community health systems, the University at Buffalo, physicians, and private industry to develop innovative treatments and technologies for vascular medicine.

Geoff Klass has a B.S. Commerce from Niagara University and has completed an Executive Development Program from the General Electric Company. Geoff has experience in management development, business development, executive development, and Six Sigma.

Some individuals on their team include Opeolu Adeoye - CMO, Paul Gaitan - CFO, and Joe Korfhagen - Director, R&D.